Nasal insulin (short-acting insulin aspart)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nasal insulin (short-acting insulin aspart), covering 2025-07-28 to 2025-07-28. Get the full timeline:
Most recent: Clinical Trial Update: Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart [Phase 1]